Alice Hudson
Psychiatric/Mental Health · Plano, TXNPI 1740567791
Payments from drug & device makers
Across 126 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$421
- Lundbeck LLC$340
- Otsuka America Pharmaceutical, Inc.$261
- Johnson & Johnson$256
- Sunovion Pharmaceuticals Inc.$221
- Supernus Pharmaceuticals, Inc.$189
- plus $675 from 12 others
What the payments were for
- Food & beverage$2,362100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,362 in reported general payments places this provider in the 75th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 17 | $127,658 |
| VraylarCariprazine Hcl | 11 | $21,442 |
| QelbreeViloxazine Hcl | 12 | $14,620 |
| DayvigoLemborexant | 11 | $3,541 |
| Paliperidone ErPaliperidone | 11 | $1,098 |
| Clozapine | 23 | $867 |
| Vilazodone Hcl | 12 | $812 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $483 |
| Gabapentin | 17 | $182 |
| Zolpidem Tartrate | 13 | $152 |
| Alprazolam | 23 | $118 |
| Benztropine Mesylate | 14 | $100 |
| Fluoxetine Hcl | 26 | $65 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $55 | $127,65817 claims |
| AbbVieVraylar | $421 | $21,44211 claims |
| Supernus Pharmaceuticals, Inc.Qelbree | $189 | $14,62012 claims |
| Eisai Inc.Dayvigo | $56 | $3,54111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Plano
- Christina ZazayPlano$16K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.